(PharmaNewsWire.Com, May 19, 2017 ) Publisher's new report, "United States Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures Outlook to 2023", provides key procedures data on the United States Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures. The report provides procedure volumes within market segments - ERCP Metal Pancreatic and Biliary Stenting Procedures and ERCP Plastic Pancreatic and Biliary Stenting Procedures.
The data in the report is derived from dynamic market forecast models. Publisher uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
- United States Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures volumes by segments - ERCP Metal Pancreatic and Biliary Stenting Procedures and ERCP Plastic Pancreatic and Biliary Stenting Procedures. - Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons to buy
- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future. - Develop market-entry and market expansion strategies.
Table of Content: 1.1 List of Tables 3 1.2 List of Figures 3 2 Introduction 4 2.1 What Is This Report About? 4 2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures, Segmentation 4 2.3 Definitions of Procedures Covered in the Report 5 3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures, United States 6 3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures, United States, 2009-2016 6 3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures, United States, 2016-2023 8 3.2.1 ERCP Metal Pancreatic and Biliary Stenting Procedures, United States, 2009-2016 10 3.2.2 ERCP Metal Pancreatic and Biliary Stenting Procedures, United States, 2016-2023 12 4 Appendix 14 4.1 Research Methodology 15 4.1.1 Coverage 15 4.1.2 Secondary Research 15 4.1.3 Primary Research 16 4.1.4 Market Modeling and Forecasting 17 4.1.5 Company Share Analysis 18 4.1.6 Distribution Share Analysis 19 4.1.7 Benchmarking 19 4.2 Publisher Consulting 19 4.3 Contact Us 20 4.4 Disclaimer 20
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
